REDITUX 500MG INJECTION contains Rituximab which belongs to the group of medicines called Anticancer drugs. It is used to manage blood cancer (leukaemia) and lymph cancer (lymphoma). It can also be used to manage various auto-immune disease conditions such as rheumatoid arthritis, granulomatosis with polyangiitis or microscopic polyangiitis (inflammation of blood vessels) and pemphigus vulgaris (severe skin blistering and peeling especially on the mouth, nose, throat, eyes and genitals).
It is mostly used in combination with other cytotoxic anticancer agents to achieve better results. It is suitable for use both in adults and in children (aged 6 months or older). REDITUX 500MG INJECTION will be administered to you only by an oncologist or a trained professional into your vein (as intravenous infusion).
Before receiving REDITUX 500MG INJECTION inform your doctor if you have any heart problems (such as chest pain, heart attack, heart failure or abnormal heartbeat). You must also inform your doctor if you currently have or previously had hepatitis B infection or any other mild infections (including minor cough and cold) as a precaution.
REDITUX 500MG INJECTION is not recommended for use in pregnant or breastfeeding women. Both men and women receiving REDITUX 500MG INJECTION must use a suitable contraceptive method to avoid pregnancy while undergoing therapy with REDITUX 500MG INJECTION.
The most common side effects of receiving this medicine are fever, chills, skin rashes with itching, shortness of breath and low blood pressure. Consult your doctor if any of these side effect worsens.
No content available
